Growth Metrics

Novartis Ag (NVS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to -$92.0 million.

  • Novartis Ag's Other Non Operating Income fell 37878.79% to -$92.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$136.0 million, marking a year-over-year decrease of 19714.29%. This contributed to the annual value of -$136.0 million for FY2025, which is 19714.29% down from last year.
  • As of Q4 2025, Novartis Ag's Other Non Operating Income stood at -$92.0 million, which was down 37878.79% from -$20.0 million recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Other Non Operating Income registered a high of $104.0 million during Q1 2023, and its lowest value of -$92.0 million during Q4 2025.
  • Over the past 5 years, Novartis Ag's median Other Non Operating Income value was $15.5 million (recorded in 2022), while the average stood at $8.9 million.
  • Per our database at Business Quant, Novartis Ag's Other Non Operating Income skyrocketed by 43125.0% in 2023 and then tumbled by 37878.79% in 2025.
  • Over the past 5 years, Novartis Ag's Other Non Operating Income (Quarter) stood at -$26.0 million in 2021, then skyrocketed by 192.31% to $24.0 million in 2022, then fell by 25.0% to $18.0 million in 2023, then soared by 83.33% to $33.0 million in 2024, then crashed by 378.79% to -$92.0 million in 2025.
  • Its Other Non Operating Income stands at -$92.0 million for Q4 2025, versus -$20.0 million for Q3 2025 and -$41.0 million for Q2 2025.